- Home
- OCGN vs TTRX Comparison
OCGN vs TTRX Comparison
Compare OCGN & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- TTRX
- Stock Information
- Founded
- OCGN 2013
- TTRX 2015
- Country
- OCGN United States
- TTRX United States
- Employees
- OCGN N/A
- TTRX N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- TTRX Biotechnology: Pharmaceutical Preparations
- Sector
- OCGN Health Care
- TTRX Health Care
- Exchange
- OCGN Nasdaq
- TTRX Nasdaq
- Market Cap
- OCGN 321.7M
- TTRX 257.8M
- IPO Year
- OCGN N/A
- TTRX N/A
- Fundamental
- Price
- OCGN $1.19
- TTRX $3.43
- Analyst Decision
- OCGN Strong Buy
- TTRX
- Analyst Count
- OCGN 2
- TTRX 0
- Target Price
- OCGN $7.00
- TTRX N/A
- AVG Volume (30 Days)
- OCGN 3.2M
- TTRX 105.2K
- Earning Date
- OCGN 11-05-2025
- TTRX 01-01-0001
- Dividend Yield
- OCGN N/A
- TTRX N/A
- EPS Growth
- OCGN N/A
- TTRX N/A
- EPS
- OCGN N/A
- TTRX N/A
- Revenue
- OCGN $5,370,000.00
- TTRX N/A
- Revenue This Year
- OCGN N/A
- TTRX N/A
- Revenue Next Year
- OCGN N/A
- TTRX N/A
- P/E Ratio
- OCGN N/A
- TTRX N/A
- Revenue Growth
- OCGN 14.26
- TTRX N/A
- 52 Week Low
- OCGN $0.52
- TTRX $2.57
- 52 Week High
- OCGN $1.90
- TTRX $26.50
- Technical
- Relative Strength Index (RSI)
- OCGN 36.58
- TTRX N/A
- Support Level
- OCGN $1.14
- TTRX N/A
- Resistance Level
- OCGN $1.22
- TTRX N/A
- Average True Range (ATR)
- OCGN 0.08
- TTRX 0.00
- MACD
- OCGN -0.01
- TTRX 0.00
- Stochastic Oscillator
- OCGN 28.79
- TTRX 0.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").